Dr. Martens plc (LON:DOCS – Get Free Report) was down 9.6% on Friday . The company traded as low as GBX 72.30 and last traded at GBX 73.80. Approximately 4,733,644 shares changed hands during trading, an increase of 115% from the average daily volume of 2,203,986 shares. The stock had previously closed at GBX 81.60.
Analysts Set New Price Targets
Separately, Peel Hunt reiterated a “buy” rating on shares of Dr. Martens in a report on Thursday. One analyst has rated the stock with a Buy rating and two have assigned a Hold rating to the company. According to data from MarketBeat, the company presently has an average rating of “Hold” and a consensus price target of GBX 6,000.
Check Out Our Latest Report on Dr. Martens
Dr. Martens Stock Performance
Dr. Martens (LON:DOCS – Get Free Report) last issued its quarterly earnings data on Thursday, November 20th. The company reported GBX (0.90) earnings per share for the quarter. Dr. Martens had a return on equity of 18.91% and a net margin of 7.89%. On average, analysts expect that Dr. Martens plc will post 2.5809394 EPS for the current year.
Insider Activity
In related news, insider Giles Wilson sold 30,000 shares of Dr. Martens stock in a transaction that occurred on Monday, September 1st. The stock was sold at an average price of GBX 91, for a total value of £27,300. Also, insider Ije Nwokori sold 298,675 shares of the stock in a transaction that occurred on Wednesday, October 15th. The shares were sold at an average price of GBX 90, for a total transaction of £268,807.50. In the last three months, insiders bought 136,960 shares of company stock valued at $12,460,163 and sold 434,460 shares valued at $39,131,400. Corporate insiders own 2.80% of the company’s stock.
Dr. Martens Company Profile
Founded in 1960, Dr. Martens is an iconic British brand with a global presence. “Docs” or “DMs” were originally
produced for their durability for workers, before being adopted by diverse youth subcultures and associated musical
movements. Today, Dr. Martens has transcended its roots while still celebrating its proud history.
See Also
- Five stocks we like better than Dr. Martens
- Consumer Discretionary Stocks Explained
- MP Materials Stock Soared After Earnings—Here’s the Real Reason
- 3 REITs to Buy and Hold for the Long Term
- Why Palantir Slide May Be a Setup for a Long-Term Opportunity
- Basic Materials Stocks Investing
- Attention Income Investors: This REIT Is on Sale
Receive News & Ratings for Dr. Martens Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Dr. Martens and related companies with MarketBeat.com's FREE daily email newsletter.
